FRIDAY, Dec. 2, 2022 (HealthDay News) — It’s thought that for an HIV vaccine to be widely effective, it will have to spur the body to make special antibodies that can neutralize a broad range of HIV strains. Now scientists say they have taken an essential step in that direction.Continue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Black adults who undergo a common procedure to open up clogged arteries are readmitted to the hospital more often than their white peers. They’re also more likely to die in the years after treatment, a new study finds. Researchers looked at how patientsContinue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — The experimental Alzheimer’s drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelling and brain bleeds remain. In the eagerly awaited trial findings, published Tuesday in the New EnglandContinue Reading
TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer’s drug, calling into question the medication’s safety. A 65-year-old woman with early-stage Alzheimer’s recently died from a massive brain bleed that some researchers link to lecanemab, anContinue Reading
MONDAY, Nov. 28, 2022 (HealthDay News) — Before Andrea Acerra, 45, had a hysterectomy due to heavy periods in November, she received an iron infusion to boost her red blood cell count and stave off the need for a transfusion. “I was just worried about side effects from the iron,Continue Reading
TUESDAY, Nov. 22, 2022 (HealthDay News) — Researchers have found a way to safely deliver a steady supply of chemotherapy directly to brain tumors — in what they hope will be an important advance for patients with currently incurable cancers. The treatment involves an implantable pump system that supplies aContinue Reading
TUESDAY, Nov. 22, 2022 (HealthDay News) — Annual lung cancer screening for heavy smokers can provide a big boost in lung cancer survival over the long term, a new study shows. When low-dose CT screening identifies early-stage lung cancer, patients have an 80% chance of surviving 20 years, researchers found.Continue Reading
FRIDAY, Nov. 18, 2022 (HealthDay News) — A severely paralyzed person no longer needs to go through brain surgery to try and steer a motorized wheelchair with their mind, researchers report. Through an electrode-studded cap placed on their head, several people with quadriplegia — no function in all four limbsContinue Reading
FRIDAY, Nov. 18, 2022 (HealthDay News) — It might be tempting to buy prescription medication online, but buyers should beware, the U.S. Food and Drug Administration warns. While some pharmacy websites operate legally and can offer convenience, privacy and lower costs, others may be selling unapproved, counterfeit and unsafe medications,Continue Reading
TUESDAY, Nov. 15, 2022 (HealthDay News) — Too few people are getting screened for lung cancer. This is the message from the American Lung Association’s 2022 “State of Lung Cancer” report. Less than 6% of eligible Americans have been screened for lung cancer, and in some states, lung cancer screeningContinue Reading
TUESDAY, Nov. 15, 2022 (HealthDay News) — Patients with advanced ankle osteoarthritis have two surgical options to restore their quality of life, and the good news is a new study shows both have good outcomes. Deciding which one is better depends on the patient. “Our aim in this trial wasContinue Reading
MONDAY, Nov. 14, 2022 (HealthDay News) — The EpiPen is a known lifesaver when someone with a serious food allergy eats something they can’t tolerate. Yet the auto-injection treatment is greatly underused in the United States, according to a new survey. Just over half of at-risk adults said they hadContinue Reading
FRIDAY, Nov. 11, 2022 (HealthDay News) — The breast cancer of author and poet Stephanie Gangi has receded and advanced in wearying waves for two decades now. First diagnosed and treated in 1999, Gangi’s cancer spread to the bone of her sternum in 2014. In 2021, a tumor the sizeContinue Reading
THURSDAY, Nov. 10, 2022 (HealthDay News) — Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say. A team used the gene editing tool CRISPR to alter immune cells drawn from 16 patients who had a variety of solidContinue Reading